Pages

Pages

Sunday, 31 July 2016

5-Fluoro-2-(4-(methylsulfonyl)-phenyl)pyridine



5-Fluoro-2-(4-(methylsulfonyl)-phenyl)pyridine

1H NMR (400 MHz, DMSO-d6) δ 8.73 (d, J = 2.8 Hz, 1H), 8.31 (bd, J = 8.8 Hz, 2H), 8.20 (dd, J = 8.8, 4.3 Hz, 1H), 8.04 (bd, J = 8.5 Hz, 2H), 7.91 (td, J = 8.8, 3.0 Hz, 1H), 3.27 (s, 3H). 

13C (100.6 MHz, DMSO-d6) 158.3, 151.3, 142.7, 141.3, 138.4, 128.0, 127.8, 125.0, 124.8, 123.3, 123.2, 44.0. 

HRMS calcd for C12H11FNO2S (M + H)+ 252.0489, found, 252.0485.

Paper

Development of Large-Scale Routes to Potent GPR119 Receptor Agonists

API Chemistry Department, Analytical Science & Development Department, #Medicinal Chemistry Department, and§Particle Sciences and Engineering Department, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States
Org. Process Res. Dev., Article ASAP
Publication Date (Web): July 13, 2016
Copyright © 2016 American Chemical Society

Abstract

Abstract Image
Practical and scalable syntheses were developed that were used to prepare multikilogram batches of GSK1292263A (1) and GSK2041706A (15), two potent G protein-coupled receptor 119 (GPR119) agonists. Both syntheses employed relatively cheap and readily available starting materials, and both took advantage of an SNAr synthetic strategy.

//////////

No comments:

Post a Comment